標(biāo)題: Titlebook: Basic and Clinical Concepts of Lung Cancer; Heine H. Hansen Book 1989 Kluwer Academic Publishers 1989 Staging.adjuvant therapy.bone marrow [打印本頁(yè)] 作者: ACE313 時(shí)間: 2025-3-21 19:48
書目名稱Basic and Clinical Concepts of Lung Cancer影響因子(影響力)
書目名稱Basic and Clinical Concepts of Lung Cancer影響因子(影響力)學(xué)科排名
書目名稱Basic and Clinical Concepts of Lung Cancer網(wǎng)絡(luò)公開(kāi)度
書目名稱Basic and Clinical Concepts of Lung Cancer網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書目名稱Basic and Clinical Concepts of Lung Cancer被引頻次
書目名稱Basic and Clinical Concepts of Lung Cancer被引頻次學(xué)科排名
書目名稱Basic and Clinical Concepts of Lung Cancer年度引用
書目名稱Basic and Clinical Concepts of Lung Cancer年度引用學(xué)科排名
書目名稱Basic and Clinical Concepts of Lung Cancer讀者反饋
書目名稱Basic and Clinical Concepts of Lung Cancer讀者反饋學(xué)科排名
作者: Fermentation 時(shí)間: 2025-3-21 20:52
The Impact of Prophylactic Methods in the Control of Lung Cancer in the U.S.A.,is the most common cause of cancer deaths among men in the United States, and recent trends suggest that it may soon surpass breast cancer mortality in women, thereby becoming the leading cause of cancer deaths among women [1,2]. Approximately 85% of these lung cancer deaths are preventable; they re作者: 說(shuō)不出 時(shí)間: 2025-3-22 00:30
Advances in the Diagnosis of Lung Tumors,contributions are to determine whether a particular tumor falls into the small-cell or non-small-cell category, and to provide data from biopsies and surgical resections that can be used in clinical staging. In the past two decades, exploitation of newer technical procedures has greatly expanded the作者: 完整 時(shí)間: 2025-3-22 06:50
Immunohistochemistry of Lung Cancer: Cell differentiation and Growth Properties,method it has become possible to visualize various intra- and extracellular substances that could not be identified by conventional histochemical methods on histology sections. The method itself is not complicated and can be performed routinely by histopathology technicians.作者: Allergic 時(shí)間: 2025-3-22 12:25
Oncogenes and Human Lung Cancer, for patients whose tumors cannot be completely resected remains grim. Obviously, the surgical and radiotherapeutic treatment modalities are approaching the limits of their potential efficacies, and the early promise of combination chemotherapy has only partially been realized. New cytotoxic agents 作者: PAD416 時(shí)間: 2025-3-22 13:18
Autocrine Growth Factors and Lung Cancer,isease prior to systemic dissemination, and the inadequacy of our systemic therapies for this disease [2]. The enormous investment of the National Cancer Institute and others in empiric new drug development has not had the same impact in lung cancer and other solid tumors as was seen in the hematolo作者: Living-Will 時(shí)間: 2025-3-22 18:13
Cytogenetic Abnormalities in Lung Cancer,d a better prediction of prognosis, and proved useful for the detection of malignant cells present in low frequency in the bone marrow samples. An example of the usefulness of chromosomal analysis in the myeloid leukemias is the identification of the Philadelphia chromosome in Chronic Granulocytic L作者: Tdd526 時(shí)間: 2025-3-23 00:27
Clinical Correlation of Tumor Endocrine Markers in Lung Cancer,osed in the United States in 1988 and that there will be 110,000 deaths from this disease. The significance of lung cancer as a cause of morbidity can be further assessed by recognizing that lung cancer accounts for 35% of all cancer deaths in males and 19% of all cancer deaths in females. Indeed in作者: 上下連貫 時(shí)間: 2025-3-23 04:10
Can Human Small-Cell Lung Cancer Cell Lines be Applied for Optimizing Chemotherapy?, reported to be 80–90%, with a complete response rate of 20–25% in extensive disease and 50–60% in limited disease. The corresponding median survival data were seven to 11 months and 10 to 15 months respectively. Unfortunately, substantial therapeutic progress does not appear to have been made since作者: 救護(hù)車 時(shí)間: 2025-3-23 05:54
Interferons and Lung Cancer: Preclinical and Clinical Investigations,Despite recent improvements in palliative therapy, long-lasting disease-free survival in a significant number of patients has not been achieved, and the cytotoxic agents currently used are capable of producing considerable toxicity. Clearly, new regimes and particularly more effective novel agents a作者: PANEL 時(shí)間: 2025-3-23 12:48
Current Staging of Lung Cancer: An Overview of Current and Newer Approaches, emphasis on both standard staging and newer techniques. Because of their clinical relevancy, small-cell (SCLC) and non-small-cell (NSCLC) lung cancers have been divided to emphasize the special needs and approaches to each.作者: definition 時(shí)間: 2025-3-23 17:56
Prognostic Factors in Adenocarcinoma of the Lung,g cancer types. Some centers have observed that the incidence of ACL is increasing faster than for other histologic types [2,3,4], and some reports [5,6,7,8], but not all [9], suggest that ACL is the most frequently occurring histologic type.作者: 細(xì)絲 時(shí)間: 2025-3-23 19:12
Surgical Adjuvant Therapy of Non-Small-Cell Lung Cancer,e patients will have disease confined to the thorax without clinical evidence of dissemination (figure 14.1). About 20% will have stage I disease, 30% will have more advanced local disease, some of whom can be resected surgically with a low expectation of cure, and others with tumor localized to the作者: Excise 時(shí)間: 2025-3-23 23:58 作者: 多產(chǎn)子 時(shí)間: 2025-3-24 05:31 作者: 大包裹 時(shí)間: 2025-3-24 07:05 作者: 專橫 時(shí)間: 2025-3-24 14:16
Long-Haul Optical Communications, countries [1], Developing countries account for approximately 2.3 million of the global 4.3 million cancer deaths and for 3.2 million of the 6.3 million new cancer cases worldwide each year [2,3]. Thus, in absolute figures, the majority of the world’s cancer patients are in the developing countries作者: Cytology 時(shí)間: 2025-3-24 18:00
A Review of the Current State of the Artis the most common cause of cancer deaths among men in the United States, and recent trends suggest that it may soon surpass breast cancer mortality in women, thereby becoming the leading cause of cancer deaths among women [1,2]. Approximately 85% of these lung cancer deaths are preventable; they re作者: 脫離 時(shí)間: 2025-3-24 21:40 作者: SHOCK 時(shí)間: 2025-3-25 00:54
Double-Orifices Pneumatic Servo Valve,method it has become possible to visualize various intra- and extracellular substances that could not be identified by conventional histochemical methods on histology sections. The method itself is not complicated and can be performed routinely by histopathology technicians.作者: 裝飾 時(shí)間: 2025-3-25 04:46
https://doi.org/10.1007/978-981-15-2202-4 for patients whose tumors cannot be completely resected remains grim. Obviously, the surgical and radiotherapeutic treatment modalities are approaching the limits of their potential efficacies, and the early promise of combination chemotherapy has only partially been realized. New cytotoxic agents 作者: Constant 時(shí)間: 2025-3-25 10:24
High Speed Rail and Access Transit Networksisease prior to systemic dissemination, and the inadequacy of our systemic therapies for this disease [2]. The enormous investment of the National Cancer Institute and others in empiric new drug development has not had the same impact in lung cancer and other solid tumors as was seen in the hematolo作者: Ointment 時(shí)間: 2025-3-25 14:57
https://doi.org/10.1007/978-3-319-61415-1d a better prediction of prognosis, and proved useful for the detection of malignant cells present in low frequency in the bone marrow samples. An example of the usefulness of chromosomal analysis in the myeloid leukemias is the identification of the Philadelphia chromosome in Chronic Granulocytic L作者: 開(kāi)花期女 時(shí)間: 2025-3-25 17:56
High Speed Railway Track Dynamicsosed in the United States in 1988 and that there will be 110,000 deaths from this disease. The significance of lung cancer as a cause of morbidity can be further assessed by recognizing that lung cancer accounts for 35% of all cancer deaths in males and 19% of all cancer deaths in females. Indeed in作者: Conspiracy 時(shí)間: 2025-3-25 21:08
https://doi.org/10.1007/978-981-10-2039-1 reported to be 80–90%, with a complete response rate of 20–25% in extensive disease and 50–60% in limited disease. The corresponding median survival data were seven to 11 months and 10 to 15 months respectively. Unfortunately, substantial therapeutic progress does not appear to have been made since作者: ensemble 時(shí)間: 2025-3-26 02:31 作者: 流動(dòng)才波動(dòng) 時(shí)間: 2025-3-26 07:49 作者: HEDGE 時(shí)間: 2025-3-26 11:04 作者: Dappled 時(shí)間: 2025-3-26 14:49 作者: 金桌活畫面 時(shí)間: 2025-3-26 17:12
https://doi.org/10.1007/978-3-642-16570-2erapy not only induces frequent objective response rates between 75% and 95%, but also prolongs survival significantly. However, only a minority of the patients cna be considered as cured [3–5]. The five-year overall survival rate is about 5–10% and there are 10 times more long-term survivors among 作者: animated 時(shí)間: 2025-3-26 22:03 作者: 聯(lián)想記憶 時(shí)間: 2025-3-27 03:48 作者: 拍翅 時(shí)間: 2025-3-27 05:31 作者: fleeting 時(shí)間: 2025-3-27 10:11
978-1-4612-8882-4Kluwer Academic Publishers 1989作者: Deduct 時(shí)間: 2025-3-27 17:30 作者: 天然熱噴泉 時(shí)間: 2025-3-27 20:25
Immunohistochemistry of Lung Cancer: Cell differentiation and Growth Properties,method it has become possible to visualize various intra- and extracellular substances that could not be identified by conventional histochemical methods on histology sections. The method itself is not complicated and can be performed routinely by histopathology technicians.作者: 裙帶關(guān)系 時(shí)間: 2025-3-28 01:30
Can Human Small-Cell Lung Cancer Cell Lines be Applied for Optimizing Chemotherapy?, reported to be 80–90%, with a complete response rate of 20–25% in extensive disease and 50–60% in limited disease. The corresponding median survival data were seven to 11 months and 10 to 15 months respectively. Unfortunately, substantial therapeutic progress does not appear to have been made since [1].作者: 分開(kāi)如此和諧 時(shí)間: 2025-3-28 04:23
Current Staging of Lung Cancer: An Overview of Current and Newer Approaches, emphasis on both standard staging and newer techniques. Because of their clinical relevancy, small-cell (SCLC) and non-small-cell (NSCLC) lung cancers have been divided to emphasize the special needs and approaches to each.作者: 規(guī)范就好 時(shí)間: 2025-3-28 10:07
Prognostic Factors in Adenocarcinoma of the Lung,g cancer types. Some centers have observed that the incidence of ACL is increasing faster than for other histologic types [2,3,4], and some reports [5,6,7,8], but not all [9], suggest that ACL is the most frequently occurring histologic type.作者: 責(zé)問(wèn) 時(shí)間: 2025-3-28 14:05
Basic and Clinical Concepts of Lung Cancer978-1-4613-1593-3Series ISSN 0927-3042 Series E-ISSN 2509-8497 作者: ineluctable 時(shí)間: 2025-3-28 15:07 作者: 的是兄弟 時(shí)間: 2025-3-28 19:44
Double-Orifices Pneumatic Servo Valve,method it has become possible to visualize various intra- and extracellular substances that could not be identified by conventional histochemical methods on histology sections. The method itself is not complicated and can be performed routinely by histopathology technicians.作者: overture 時(shí)間: 2025-3-29 00:04
https://doi.org/10.1007/978-981-10-2039-1 reported to be 80–90%, with a complete response rate of 20–25% in extensive disease and 50–60% in limited disease. The corresponding median survival data were seven to 11 months and 10 to 15 months respectively. Unfortunately, substantial therapeutic progress does not appear to have been made since [1].作者: breadth 時(shí)間: 2025-3-29 04:47
https://doi.org/10.1007/978-981-16-4593-8 emphasis on both standard staging and newer techniques. Because of their clinical relevancy, small-cell (SCLC) and non-small-cell (NSCLC) lung cancers have been divided to emphasize the special needs and approaches to each.作者: BAN 時(shí)間: 2025-3-29 09:51 作者: 要求比…更好 時(shí)間: 2025-3-29 15:18 作者: 最有利 時(shí)間: 2025-3-29 18:00 作者: Narcissist 時(shí)間: 2025-3-29 23:27
https://doi.org/10.1007/978-3-319-05840-5Lung cancer is one of the major causes of cancer death among men and is increasing as a death factor among women in Norway [1]. During the next 10 years, about one million Americans and two million Europeans will die of lung cancer if the rate of cure remains unchanged [2].作者: aggressor 時(shí)間: 2025-3-30 00:22
Observer Variability Studies of the WHO Classification of Lung Cancer,There are very few diseases, particularly neoplasms, that have only a single classification. This fact usually reflects the incompleteness of our understanding of the disease, the imperfection of each of the classifications, and the complexity of the disease.作者: candle 時(shí)間: 2025-3-30 04:08
Psychosocial Aspects of Patients with Lung Cancer in Controlled Clinical Trials,Lung cancer is one of the major causes of cancer death among men and is increasing as a death factor among women in Norway [1]. During the next 10 years, about one million Americans and two million Europeans will die of lung cancer if the rate of cure remains unchanged [2].作者: indigenous 時(shí)間: 2025-3-30 11:56 作者: 不能強(qiáng)迫我 時(shí)間: 2025-3-30 12:33 作者: GRE 時(shí)間: 2025-3-30 18:13
Book 1989 lung cancer every minute globally. The first chapter is from the Cancer Unit, WHO, Geneva, and describes in detail the epidemiologic features of lung cancer, which is the second most frequent cancer in the world with 660,500 new cases annually; it will soon surpass stomach cancer as the leader. Thi作者: biopsy 時(shí)間: 2025-3-30 21:36
Autocrine Growth Factors and Lung Cancer,an be administered to patients, as is the case with monoclonal antibody [4], make this area especially promising. In this chapter we will review the development of growth factor research, attempting to summarize the current state of understanding of the role of growth factors especially as they rela作者: 出生 時(shí)間: 2025-3-31 02:51
CNS Therapy in Small-Cell Lung Cancer,they did become more frequent with increasing survival time [4,5]. Accordingly, those with most benefit from current treatment of SCLC are running the highest risk of developing this complication. Some of the fundamental problems in establishing the true dimension of the problem have been described 作者: 笨重 時(shí)間: 2025-3-31 08:22 作者: 虛情假意 時(shí)間: 2025-3-31 09:19
Book 1989nical Aspects. The present book continues the outline of the previous volume by presenting up-to-date information on lung cancer in critical reviews of new important basic and clinical concepts of lung cancer. The present volume has broadened the scope by also including chapters dealing with issues 作者: 青少年 時(shí)間: 2025-3-31 15:10
Oncogenes and Human Lung Cancer,with significant activity in lung cancer are difficult to find, and the results of early clinical trials with biological agents such as the interferons or interleukins raise little hope of major activity.作者: 滑稽 時(shí)間: 2025-3-31 20:38 作者: 控制 時(shí)間: 2025-3-31 23:42
Late Complications Associated with the Treatment of Small-Cell Lung Cancer,apidly, and is usually very widely disseminated at the time of diagnosis [4,5]. In contradistinction to non-small-cell lung tumors, SCLC is very responsive to single-agent chemotherapy as well as combinations, even in patients with advanced disease.
